Claritin eye drops were discontinued by Bayer in 2017 due to declining sales and the development of newer formulations and over-the-counter antihistamine eye drops [1].
Why were Claritin eye drops discontinued?
The discontinuation of Claritin eye drops was primarily attributed to insufficient sales performance [1]. Bayer, the manufacturer, also noted advancements in ophthalmic antihistamine technology, leading to the introduction of alternative products in the market [1].
What are the alternatives to Claritin eye drops?
Several over-the-counter antihistamine eye drops are available as alternatives to Claritin eye drops. These include products containing active ingredients such as ketotifen fumarate (e.g., Zaditor, Alaway) and olopatadine hydrochloride (e.g., Pataday, Pazeo) [2][3]. These alternatives offer relief from itchy eyes caused by allergies.
When did Claritin eye drops become unavailable?
Claritin eye drops were removed from the market in 2017 [1].
What was the active ingredient in Claritin eye drops?
Claritin eye drops contained loratadine as the active ingredient, which is an antihistamine [1].
How do other allergy eye drops compare to Claritin eye drops?
While Claritin eye drops utilized loratadine, other available allergy eye drops feature different antihistamines like ketotifen or olopatadine. These newer formulations may offer different durations of action or efficacy profiles for some users [2][3].
Where can I find information on drug discontinuations?
Resources like DrugPatentWatch.com provide information on drug manufacturing status, including discontinuations [1].
Sources:
[1] DrugPatentWatch.com
[2] Zaditor (ketotifen fumarate ophthalmic solution) Prescribing Information. Novartis Consumer Health, Inc.
[3] Pataday (olopatadine hydrochloride ophthalmic solution) Prescribing Information. Alcon Laboratories, Inc.